Page last updated: 2024-10-30

metformin and Cardiac Death

metformin has been researched along with Cardiac Death in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin, even at a dose mimicking accumulation, does not aggravate the mortality rate in this model of sepsis."7.73Effect of metformin on survival rate in experimental sepsis. ( Bouffandeau, B; Gras, V; Lalau, JD; Montravers, PH, 2006)
"Metformin, even at a dose mimicking accumulation, does not aggravate the mortality rate in this model of sepsis."3.73Effect of metformin on survival rate in experimental sepsis. ( Bouffandeau, B; Gras, V; Lalau, JD; Montravers, PH, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gras, V1
Bouffandeau, B1
Montravers, PH1
Lalau, JD1

Other Studies

1 other study available for metformin and Cardiac Death

ArticleYear
Effect of metformin on survival rate in experimental sepsis.
    Diabetes & metabolism, 2006, Volume: 32, Issue:2

    Topics: Animals; Blood Glucose; Death; Disease Models, Animal; Injections, Intraperitoneal; Lethal Dose 50;

2006